Evaluation of the Electronic Cigarette Withdrawal Syndrome
Start Date
11/28/2023
Completion Date
6/30/2028
Summary
The goal of this project is to rigorously evaluate the nature of e-cigarette withdrawal in exclusive e-cigarette users during a monitored abstinence period and the role of nicotine in the expression of this withdrawal syndrome.
Detailed Description
This project will use a rigorous residential laboratory design to evaluate e-cigarette withdrawal expression and experimentally determine the role of nicotine in this syndrome. Healthy adults who exclusively use e-cigarettes will undergo monitored e-cigarette abstinence over seven days (1 week) in a residential unit. The investigators will evaluate the contribution of nicotine to withdrawal expression by assigning participants to one of three conditions: active nicotine patch, placebo patch control, or no patch to control for expectancies. Standardized behavioral and biological measures associated with withdrawal including patient report, cognitive task performance, and biometrics will be collected throughout to establish a rigorous timecourse of withdrawal and evaluate the contribution of nicotine to these symptoms.
Eligibility Criteria
Age Range: 21 years to 55 years
Interventions
Transdermal Nicotine Patch
Placebo Nicotine Patch
Conditions
Locations
Behavioral Pharmacology Research Unit
Baltimore, Maryland 21224
United States